EVOK - Evoke Pharma Inc Stock Price, Fair Value and News

$5.07-0.42 (-7.65%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

EVOK Price Action

Last 7 days

7.6%

Last 30 days

11.2%

Last 90 days

12.4%

Trailing 12 Months

-63.1%

EVOK RSI Chart

EVOK Valuation

Market Cap

7.5M

Price/Earnings (Trailing)

-1.23

Price/Sales (Trailing)

0.87

Price/Free Cashflow

-1.41

EVOK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

EVOK Fundamentals

EVOK Revenue

Revenue (TTM)

8.6M

Rev. Growth (Yr)

69.83%

Rev. Growth (Qtr)

4.03%

EVOK Earnings

Earnings (TTM)

-6.1M

Earnings Growth (Yr)

22.52%

Earnings Growth (Qtr)

-3.56%

EVOK Profitability

Return on Equity

-140.11%

Return on Assets

-43.43%

Free Cashflow Yield

-70.68%

EVOK Investor Care

Shares Dilution (1Y)

433.41%

Diluted EPS (TTM)

-11.03

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	6.1M	7.5M	8.6M	0
2023	2.9M	3.6M	4.3M	5.2M
2022	1.9M	2.2M	2.1M	2.5M
2021	111.9K	347.4K	1.3M	1.6M
2020	0	0	0	23.0K
2015	7.7K	5.6K	4.3K	0
2014	9.9K	12.3K	13.4K	10.2K
2013	3.1K	4.5K	5.9K	7.2K
2012	0	0	6.2K	1.7K
2011	0	0	0	10.7K

Get all data in R, Python etc through our Historical Stock Data APIs

About Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

CEO	Mr. David A. Gonyer R.Ph.
WEBSITE	https://evokepharma.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	4

Evoke Pharma Inc Frequently Asked Questions

What is the ticker symbol for Evoke Pharma Inc? What does EVOK stand for in stocks?

EVOK is the stock ticker symbol of Evoke Pharma Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Evoke Pharma Inc (EVOK)?

As of Fri Dec 20 2024, market cap of Evoke Pharma Inc is 7.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EVOK stock?

You can check EVOK's fair value in chart for subscribers.

Is Evoke Pharma Inc a good stock to buy?

The fair value guage provides a quick view whether EVOK is over valued or under valued. Whether Evoke Pharma Inc is cheap or expensive depends on the assumptions which impact Evoke Pharma Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EVOK.

What is Evoke Pharma Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, EVOK's PE ratio (Price to Earnings) is -1.23 and Price to Sales (PS) ratio is 0.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EVOK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Evoke Pharma Inc's stock?

In the past 10 years, Evoke Pharma Inc has provided -0.399 (multiply by 100 for percentage) rate of return.